Last edition
News about "human Telomerase Reverse Transcriptase"
BioViva Secures US Patent for hTERT and Follistatin-344 Combination Therapy
BioViva has received a US patent covering therapeutic methods that combine hTERT and Follistatin-344, expanding its intellectual-property portfolio focused on genetic approaches to aging.
Human Telomerase Reverse Transcriptase | 15/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members